Texas · 89th Legislature (2025) · Bill
HB 3086: Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 3086 is a bill introduced in the Texas House on February 20, 2025. According to its official title, it concerns: Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs. Primary sponsor: Tom Oliverson (Republican). Most recent recorded action (March 20, 2025): Referred to Public Health.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Tom Oliverson | Primary sponsor | Republican | House | 130 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to Public Health
- Read first time
- Filed